Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
Farquhar VC's Jason Su and S&S Lab's Kim Minsoo S&S Lab, a shared research lab and the operator of IRIS ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.